All Type of News
Kolon Life Science’s Invossa Inj to achieve 1,500 procedures
Kolon Life Science(CEO Woo-Seok Lee) announced they acquired approval of Invossa on July 2017, started to sell the product on November and achieved more than 1,500 procedures to July 2018 for 9 months.
According to t...
1,660 Korean people deliver signatures for ‘Opposition to Tylenol’ to MOHW
The pharmaceutical society and people delivered signatures to immediately suspend convenient stores to sell Tylenols and suggested the ‘National Task on Public Late-Night Pharmacy.’
The Society for the Future of Phar...
Medytox, Hugel and Chong Kun Dang Holdings ranked top in market value
Medytox, Hugel, and Chong Kun Dang Holdings were ranked higher in market value among other small and medium biopharmaceutical companies listed in Asian securities markets.
According to the ‘Forbes Asian Small and Med...
57 Chinese Rundu’s Valsartan products suspended health insurance benefits
Betond Huahai’s ingredients, there were other Valsartan products with issues.
The Ministry of Health and Welfare(MOHW) gave a notice about this through its own system to inform about products with suspended health in...
‘Valsartan’ products using Chinese ingredients detected too much ‘NDMA’
The Ministry of Food and Drug Safety(MFDS) announced on the 6th that Daebong LS went exceeded with the regulated level of NDMA, a carcinogenic factor, by using the Chinese ‘Varsartan’ ingredients in processing their p...
Convenient store association, “Selling emergency household medicines is not greed, but contribution”
While the pharmaceutical society and the convenient store field are opposing each other over emergency household medicines, the convenient store association once again refuted what the pharmaceutical association refut...
AI-based precision medicine service ‘Dr. Answer’ first introduced at event
An event was arranged to take a glance of future AI-based precision medicine services in development and their future directions.
The Ministry of Science, ICT and Future Planning(Minister Young-Min Yoo, MSIP) and the...
KPA, “We’ve never asked KRW 4.5 million for operating public late-night pharmacies”
The pharmaceutical association refuted that it was not true they requested KRW 4.5 million for public late-night pharmacy.
The Korea Pharmaceutical Association(KPA) announced in a refutation statement on the 4th that...
Daewoong finishes resubmitting documents for Nabota to FDA
Daewoong Pharmaceutical’s botulinum toxin ‘Nabota’ has taken the last step to enter the U.S. market.
Daewoong Pharmaceutical(CEO Seung-Ho Jeon) announced on the 2nd that they turned in revised documents to the U.S. F...
70 Korean pharmas including Yuhan Corporation participate in ‘CPhI Worldwide 2018’
About 70 Korean pharmaceutical companies will participated in the world’s largest pharmaceutical conference held in Madrid, Spain on the coming 10th ‘CPhI Worldwide 2018’ and start to pioneer new exporting markets.
T...
